• Sun, December 1, 2024

by: Thomas Matters

What does October's HOT retail data mean for interest rates and ASX 200 investors?

The cost of living crunch isn't keeping Aussie consumers from spending big. The post What does October's HOT retail data mean for interest rates and ASX 200 investors? appeared first on The Motley Fool Australia.

by: Thomas Matters

The top 3 ASX 200 stocks to buy and hold in November revealed

These three ASX 200 stocks led the charge higher in November. Own any? The post The top 3 ASX 200 stocks to buy and hold in November revealed appeared first on The Motley Fool Australia.

by: Thomas Matters

Best Undervalued Stocks for November 2024

Value investing is the strategy of buying stocks whose prices don't reflect what the underlying company is fundamentally worth. When successful, value investors stock up on high-quality ...

by: Thomas Matters

Fund manager's stock-pick focus includes a key Nvidia partner

The fund has succeeded both in the investor class fund (CEMVX) and its institutional class (CEMIX) . The funds are up about 18.4% so far in 2024 and have risen more than 30% over the past 12 months. The MSCI index is up 11.

by: Thomas Matters

Nvidia: Still Charging Ahead

Nvidia is reporting unsustainable margins that will normalize over the long term. Read why investors should continue riding the trend with NVDA stock.

by: Thomas Matters

Why this ASX healthcare share is soaring 26% on study findings

  • Mon, December 2, 2024

by: Thomas Matters

Intuitive Surgical assumed at Overweight from Equal Weight at Morgan Stanley

by: Thomas Matters

Nasdaq, S&P, and Dow are mixed while Treasury yield inversion talks resume

Wall Street's major market averages were mixed on Monday as traders and investors await a plethora of economic data releases over the week.

by: Thomas Matters

Goldman Sachs: Go back to this investing strategy that beat the market during Trump's first term

M&A dealmaking activity is about to boom, according to Goldman Sachs. Here's how you can leverage that for index-beating portfolio returns.

by: Thomas Matters

Why Is Amazon.com, Inc. (AMZN) Among the Stocks Ray Dalio's Bridgewater Is Crazy About

by: Thomas Matters

Buffett Pick Kroger Just Paid Investors: Here's How Much They Got

Wall St. Insights Kroger Co. (NYSE: KR) just rewarded its shareholders again with a quarterly dividend. This Warren Buffett favorite has hiked its dividend annually for more than 17 years. Also: 2 Dividend Legends to Hold Forever.

by: Thomas Matters

November Turns S&P 500's Best Month in 2024: ETF Area Winners

by: Thomas Matters

Markets surge to record highs, Santa rally speculation continues, XRP comes out of the dark

by: Thomas Matters

Billionaires Ray Dalio, Philippe Laffont, and Stanley Druckenmiller Are Selling Shares of Nvidia and Piling Into This Artificial Intelligence Stock-Split Player

Billionaire investors have flocked to artificial intelligence (AI) stocks in recent times, and many have scored major wins by investing early in today's market giant: Nvidia (NASDAQ: NVDA). Shares of the leading AI chipmaker are heading for a gain of about 170% this year and have climbed 2,

by: Thomas Matters

How Is HCA Healthcare's Stock Performance Compared to Healthcare Provider Stocks?

HCA Healthcare, Inc. (HCA), a leading player in the healthcare industry, was founded in 1968 and is headquartered in Nashville, Tennessee. With a market cap of $82.9 billion, HCA operates one of the largest networks of healthcare facilities in the U.

by: Thomas Matters

SPYD: High-Yield Might Have More Risk Than Benefit

SPDR® Portfolio S&P 500® High Dividend ETF offers dividend growth with lower volatility. Find out why SPYD is a solid hold amid economic slowdown risks.

by: Thomas Matters

JGG-MON-Which of these UK stocks is the better bargain in December?

Stephen Wright thinks Diageo and Senior are very different UK stocks with very similar prospects. But which one offers better value at the moment?

by: Thomas Matters

Stocks in play: Gear Energy Ltd.

by: Thomas Matters

B2Gold Continuing to Operate at Fekola Mine Despite Temporary Labour Action; Implementation of MOU with State of Mali Continues

by: Thomas Matters

I invested over $55k in Tesla's stock - now it's worth $550k and I'm looking for the best tax strategy for selling my position

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. 24/7 Wall St. : For any investor facing capital gains, the key to success is understanding tax implications and planning your finances accordingly.

by: Thomas Matters

Best Energy Stocks for November 2024

These are some of the best-performing stocks in the energy sector over the past month Bloomberg/Getty Images Energy sector stocks—including those exploring for and developing oil and gas ...

by: Thomas Matters

Stock market today: Indexes trade mixed as traders take a breather after the best month of 2024

There was a 3.4% year-over-year increase in US retail sales on Black Friday, with online sales driving the bulk of the gains, according to Mastercard

by: Thomas Matters

Warren Buffett's Contrarian Bets on 2 Stocks Bank of America Warns Against

Investors are constantly on the lookout for an edge and one of the best ways to do that is by following in the footsteps of Wall Street's most

by: Thomas Matters

December's premium bond winners revealed - do bonds make good Christmas gifts?

Two lucky premium bond holders have become millionaires after winning the jackpot in the National Savings & Investments (NS&I) December draw. The £1m winners are from Kent and Cumbria. Meanwhile, 84 other winners bagged the next-best prize of £100,

by: Thomas Matters

Top 5 Crypto to Buy This December for a Wealthy Retirement

by: Thomas Matters

3 Top Dividend Stocks to Buy and Hold Forever

Coca-Cola has paid a growing dividend for over half a century and continues to invest in opportunities. Home Depot has a long track record of dividend growth and outperforming the broad market. Dividend superstar Realty Income has paid a monthly dividend for more than 54 years.

by: Thomas Matters

Arista Networks, Palo Alto To Join Nvidia, Broadcom, Super Micro In 2024 Stock Splits

Nvidia stock has gained 175% in 2024 but most of the gain came before its June stock split. Arista stock and Palo Alto stock will soon split.

by: Thomas Matters

Banks head into Q4 with investors looking for better days ahead

The majority of Canada's big banks are heading into fourth-quarter earnings this week riding high as fears around mortgage defaults and a recession ease.

by: Thomas Matters

Prediction: Nvidia Stock Will Soar in 2025, and Not Just Because the AI Boom Is Building Steam

by: Thomas Matters

2 Monster Stocks to Buy Before 2025

by: Thomas Matters

RBC's strategy team reveals their top 30 Canadian stock picks for 2025

The research team at RBC Capital Markets published their Strategy Canadian Focus List of top picks for 2025.

by: Thomas Matters

Best Energy Stocks for December 2024

These are some of the best-performing stocks in the energy sector over the past month Bloomberg/Getty Images Energy sector stocks—including those exploring for and developing oil and gas ...

by: Thomas Matters

3 Incredible Growth Stocks to Buy Right Now

Small-cap stocks are outperforming large caps post-election, with the Russell 2000 up 7.8% compared to the S&P 500's 4.4% gain. The post-election market shift has created compelling opportunities in small-cap technology stocks.

by: Thomas Matters

3 No-Brainer Warren Buffett Dividend Stocks to Buy in December

Occidental Petroleum is worthy of strong consideration for investors seeking an oil dividend stock that bears the Warren Buffett imprimatur. Daniel Foelber (Chevron): I agree with my colleague, Scott,

by: Thomas Matters

Stock index futures inch lower as investors brace for ton of economic releases in the week

by: Thomas Matters

Stock market today: World shares are mixed as Chinese stocks get a boost from strong factory orders

World shares have started the week mixed, with China leading gains as monthly surveys show improving conditions for manufacturing.

by: Thomas Matters

3 No-Brainer Stocks to Buy in December

Three stocks that I've got my eye on to buy more of in December are ASML ( ASML 2.41%), Taiwan Semiconductor Manufacturing ( TSM 1.92%), and Meta Platforms ( META 0.90%). All three of these companies are set to be long-term beneficiaries of the artificial intelligence (AI) arms race and make for great investments right now.

by: Thomas Matters

Best Health Care Stocks for December 2024

Investors may be able to benefit from these major gains. But investing in health care stocks carries risks as well. As mentioned above, it is an enormous and highly complex sector, and investors ...

by: Thomas Matters

Louisiana-Pacific: Superb Execution, But Not Worth This Much

Louisiana-Pacific has shown significant improvement in fundamentals, particularly in Siding. Read why I remain neutral on LPX stock.

by: Thomas Matters

Explained: Why FPIs are buying via IPO route and selling in stock market

FPIs have invested ₹1.03 lakh crore in the Indian primary market through IPOs and QIBs, while they pumped out ₹1.18 lakh crore through the secondary market.

by: Thomas Matters

Markets Brief: Consumer Stocks Rally, Now Some Look Pricey

Employment data on Friday is likely to provide the big news of the week as it has the potential to challenge the dominant narrative of a soft landing for the US economy. Ahead of that release the Federal Reserve will release its 'Beige Book' of anecdotal evidence from the Fed's 12 districts. You can find a full calendar of releases here.

by: Thomas Matters

After an 18% jump on its 2024 results, is it too late for me to consider buying this FTSE 100 hidden gem?

by: Thomas Matters

These five 'hold-forever' stocks offer high returns on equity and capital employed

When it comes to investing for the long term, identifying stocks that consistently deliver a high return on equity (ROE) and return on capital employed (ROCE) can be a powerful strategy. ROE and ROCE are key financial metrics that measure a company's ...

by: Thomas Matters

'Lame duck' Biden pushing major US policies before Trump's return

Cease-fire agreement in Gaza, Ukraine weapons package among initiatives Biden pressing to approve - Anadolu Ajansı

by: Thomas Matters

This tech giant has returned 228,500pc over its life and isn't about to stop

Questor is The Telegraph's stockpicking column, helping you decode the markets and offering insights on where to invest. One of Fleet Street's longest-running share tip columns, it celebrates its 60th birthday on Dec 7.

by: Thomas Matters

2 FTSE 100 and FTSE 250 value stocks to consider in December!

Searching for the best FTSE 100 and FTSE 250 bargain shares? Here, Royston Wild picks out two of his favourites this festive season.

by: Thomas Matters

Why did the Zip share price smash the market again in November?

This high-flying stock made its shareholders smile again last month. The post Why did the Zip share price smash the market again in November? appeared first on The Motley Fool Australia.

by: Thomas Matters

Indian Capital Goods Stocks Regain Investor Favor

Before the trading day starts we bring you a digest of the key news and events that are likely to move markets. Today we look at:

Why this ASX healthcare share is soaring 26% on study findings

This share is getting a lot of attention on Monday. What's happening? The post Why this ASX healthcare share is soaring 26% on study findings appeared first on The Motley Fool Australia.
The article from MSN discusses the significant surge in the share price of Telix Pharmaceuticals (ASX: TLX), an Australian healthcare company, following the release of promising study results. Telix announced that its investigational prostate cancer imaging agent, TLX591, showed positive outcomes in a Phase I study, demonstrating both safety and efficacy. This news led to a 26% increase in Telix's share price. The study involved patients with metastatic castrate-resistant prostate cancer (mCRPC), and the results indicated that TLX591 could potentially improve the visualization of cancer cells, aiding in more precise treatment. The positive data has not only boosted investor confidence but also highlighted Telix's potential in the global fight against cancer, particularly in the niche of radiopharmaceuticals.

Read the Full MSN Article at:
https://www.msn.com/en-au/lifestyle/misc/why-this-asx-healthcare-share-is-soaring-26-on-study-findings/ar-AA1v5cG1